ArticleSurgical endoscopy2026
Laparoscopic pancreatoduodenectomy and venous resection are safe in selected patients: a monocentric comparative study in 30 patients.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Robotic pancreaticoduodenectomy with venous resection and reconstruction: a systematic review of perioperative, vascular, oncological and survival outcomes.Journal of robotic surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnsuring oncologic resections margins may involve venous resection (VR) during pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC). Data regarding laparoscopic VR surgical outcomes in comparison with the open approach are lacking. Hence, we sought to compare the outcomes of laparoscopic PD (LPD) and open PD (OPD) with VR.
methodsWe retrospectively analyzed data from patients with resectable or borderline PDAC undergoing LPD or OPD with lateral or segmental portal/superior mesenteric vein resection in a high-volume center between 2012 and 2023.
resultsNinety-eight patients were included (30 LPD and 68 OPD). Patients in both groups had similar median age (62 vs 67, P = 0.166). Patients who underwent LPD had less neoadjuvant chemoradiotherapy (63% vs 91%, P = 0.003), but more lateral VR (83% vs 63%, P = 0.058), more reconstructions with a peritoneal patch (43% versus 19%, P = 0.024), longer median clamping time (28 vs 15 min, P < 0.001) and operative time (383 vs 255 min, P < 0.001). Patients in the LPD group showed similar rate of Clavien-Dindo morbidity > II (27% vs 16%, P = 0.271), 90-day mortality (3% vs 2%, P = 0.521), median length of stay (14 vs 14 days, P = 0.890), and R0 resection rate (73% vs 89%, P = 0.066) when compared to patients in the OPD group. At 6-month follow-up, venous patency rates between both groups was similar (76% vs 73%, P = 0.691).
conclusionLPD and OPD with VR have similar short-term and oncologic outcomes for patients with resectable or borderline PDAC.
Indexed as
Identifiers
41062760What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.